Intranasal nerve growth factor bypasses the blood-brain barrier and affects spinal cord neurons in spinal cord injury
Authors:
- Luigi AloeLALuigi Aloe
- Marzia SoligoMSMarzia Soligo
- Rocco MlRMRocco Ml
Open Access
- 1 January 2014
- journal article
- research article
- Published by Medknow in Neural Regeneration Research
- Vol. 9 (10) , 1025-30
Abstract
The purpose of this work was to investigate whether, by intranasal administration, the nerve growth factor bypasses the blood-brain barrier and turns over the spinal cord neurons and if such therapeutic approach could be of value in the treatment of spinal cord injury. Adult Sprague-Dawley rats with intact and injured spinal cord received daily intranasal nerve growth factor administration in both nostrils for 1 day or for 3 consecutive weeks. We found an increased content of nerve growth factor and enhanced expression of nerve growth factor receptor in the spinal cord 24 hours after a single intranasal administration of nerve growth factor in healthy rats, while daily treatment for 3 weeks in a model of spinal cord injury improved the deficits in locomotor behaviour and increased spinal content of both nerve growth factor and nerve growth factor receptors. These outcomes suggest that the intranasal nerve growth factor bypasses blood-brain barrier and affects spinal cord neurons in spinal cord injury. They also suggest exploiting the possible therapeutic role of intranasally delivered nerve growth factor for the neuroprotection of damaged spinal nerve cells.Keywords
This publication has 34 references indexed in Scilit:
- Messenger RNA expression patterns of p75 neurotrophin receptor and tropomyosin-receptor-kinase A following spinal cord injuryThe Journal of Spinal Cord Medicine, 2013
- Nerve Growth Factor Regulates the Firing Patterns and Synaptic Composition of MotoneuronsJournal of Neuroscience, 2010
- The dose-effectiveness of intranasal VEGF in treatment of experimental strokeNeuroscience Letters, 2009
- Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injurySpinal Cord, 2008
- NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the ratExperimental Neurology, 2007
- Neurotrophins: Roles in Neuronal Development and FunctionAnnual Review of Neuroscience, 2001
- Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cordMolecular Brain Research, 2001
- Transport of drugs from the nasal cavity to the central nervous systemEuropean Journal of Pharmaceutical Sciences, 2000
- Nerve Growth Factor in Glia and Inflammatory Cells of the Injured Rat Spinal CordJournal of Neurochemistry, 2000
- Fibroblasts Genetically Modified to Produce Nerve Growth Factor Induce Robust Neuritic Ingrowth after Grafting to the Spinal CordExperimental Neurology, 1994